用于瘤向治疗的基于氧酸盐的载体

相关实验视频

Updated: Jul 27, 2025

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

Gongming Qian^1,2, Lingya Xiong¹, Qing Ye^1,2

¹College of Resource and Environmental Engineering, Wuhan University of Science & Technology Wuhan 430081 China qiangongming@wust.edu.cn.

|June 5, 2023

概括

氧酸盐 (HAP) 是一种有希望的生物相容药物载体,用于向瘤治疗. 基于HAP的载体增强药物加载和细胞吸收,提高治疗疗效.

科学领域:

生物材料科学生物材料科学
纳米技术纳米技术
在瘤学瘤学.

背景情况:

针对性的药物输送对于克服常规化疗在癌症治疗中的局限性至关重要.
作为骨的主要成分,酸 (HAP) 具有出色的生物相容性,无毒性和生物降解性,使其成为药物输送系统的合适候选者.

研究的目的:

本综述探讨了酸 (HAP) 作为癌症治疗中向药物递送的载体的进展和潜力.
突出基于HAP的运营商提高药物加载效率和治疗响应的能力.

主要方法:

基于HAP的载体通过兴奋剂,修饰和组合策略来合成.
治疗剂的加载到HAP载体是通过吸附或现场加载来实现的.

主要成果:

基于HAP的载体表现出增强的药物载荷能力和对微环境刺激的提高灵敏度.
这些载体通过体内微环境指导和体内反应刺激来促进向药物输送.
基于HAP的载体观察到药物的细胞吸收率得到改善,从而改善治疗结果.

结论:

氧酸盐 (HAP) 为开发针对癌症治疗的先进药物输送系统提供了一个有前途的平台.
基于HAP的载体在药物加载,向输送和细胞吸收方面提供了显著的优势,为更有效的瘤治疗铺平了道路.

更多相关视频

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.